The role of ultrasound in the complex diagnosis of hepatocellular carcinoma

DOI: https://doi.org/10.25512/DIR.2014.08.4.03

For quoting:
Danzanova T.Yu., Sinyukova G.T., Lepedatu P.I., Medvedeva B.M., Kostyakova L.A. "The role of ultrasound in the complex diagnosis of hepatocellular carcinoma". Journal Diagnostic & interventional radiology. 2014; 8(4); 31-40.

authors:

Danzanova T.Yu.

Sinyukova G.T.

Lepedatu P.I.

Medvedeva B.M.

Kostyakova L.A.

keywords:

hepatocellular carcinoma

ultrasound

Abstract:

Aim: was to determine the possibility of ultrasound in the diagnosis of hepatocellular carcinoma (HCC).

Materials and methods: the study involved 140 patients who underwent surgical treatment for the period 1998-2013 years. HCC was confirmed in 127 patients, 12 patients had benign tumors, such as hepatocellular adenoma, focal nodular hyperplasia.

Results: ultrasound features of hepatocellular carcinoma were studied. To determine the informativeness, results were compared with preoperative methods of examination, intraoperative ultrasound (IOUS) and histological examination with surgical evaluation and histologic data. Number of tumor nodules, determined by ultrasound confirmed in 74% of cases with HCC and 83,3% for benign diseases. Dimensions, which were measured by ultrasound, were confirmed in majority cases (81,1%) with HCC and 100% of cases with benign tumors. Sensitivity and specificity of ultrasound were 99,2% and 25%, CT - 96,9% and 28,6%, MRI - 100% and 33,3% respectively Aspiration biopsy showed the most balanced performance: sensitivity - 94,9%, specificity 45,4%. Lack of true negative results during angiography, IOUS and surgical evaluation did not gave possibilities to calculate the specificity and predictive value of a negative result. Sensitivity of IOUS and surgical evaluation were 98,8% and 97,6%, respectively Of all tumor markers used in the diagnostic process, none of all showed any significant sensitivity, but they were characterized by high specificity and positive predictive method predictability

Conclusions: US strategy in the diagnosis of HCC is to identify neoplasm, conducting navigation during fine-needle aspiration biopsy, specifying diagnostics during surgery. Results showed highly informative diagnostic value of ultrasound at all stages of the examination and treatment of patients with HCC.

References

1. Ferlay J., Shin H.R., Bray F., et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer. 2010;127(12):2893-2917.

2. Dhanasekaran R., Limaye A., Cabrera R. Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis, and therapeutics. Hepat. Med. 2012 May 8;4:19-37.

3. Outwater E.K. Imaging of the liver for hepatocellular carcinoma. Cancer Control. 2010;17(2):72-82.

4. Bruix J., Sherman M. Management of hepatocellular carcinoma: an update. Hepatology. 2011 Mar;53(3): 1020-2.

5. Ding W., He X.J. Fine needle aspiration cytology in the diagnosis of liver lesions. Hepatobiliary Pancreat Dis Int. 2004;3:90-92.

6. Glockner J.F. Hepatobiliary MRI: current concepts and controversies. J. Magn. Reson. Imaging. 2007;25: 681-695.

7. Cabrera R., Nelson D.R. Review article: the management of hepatocellular carcinoma. Aliment. Pharmacol. Ther. 2010 Feb 15;31(4):461-76.

8. Fracanzani A.L., Burdick L., Borzio M., et al. Contrast-enhanced Doppler ultrasonography in the diagnosis of hepatocellular carcinoma and premalignant lesions in patients with cirrhosis. Hepatology. 2001;34:1109-1112.

9. Franga A.V., Elias Junior J., Lima B.L., et al. Diagnosis, staging and treatment of hepatocellular carcinoma. Braz. J. Med. Biol. Res. 2004;37:1689-1705.

10. Saar B., Kellner-Weldon F. Radiological diagnosis of hepatocellular carcinoma. Liver Int. 2008;28:189-199.

11. Yu S.C., Yeung D.T., So N.M. Imaging features of hepatocellular carcinoma. Clin Radiol. 2004;59:145-156.

12. Bruix J., Hessheimer A.J., Forner A., et al. New aspects of diagnosis and therapy of hepatocellular carcinoma. Oncogene. 2006;25:3848-3856.

13. Gomaa A.I., Khan S.A., Leen E.L., et al. Diagnosis of hepatocellular carcinoma. World J. Gastroenterol. 2009 Mar 21;15(11):1301-14.

14. Vilana R., Bru C., Bruix J., et al. Fine-needle aspiration biopsy of portal vein thrombus: value in detecting malignant thrombosis. AJR Am. J. Roentgenol. 1993;160: 1285-1287.

15. Pompili M., Riccardi L., Semeraro S., et al. Contrast-enhanced ultrasound assessment of arterial vascularization of small nodules arising in the cirrhotic liver. Dig. Liver Dis. 2008;40:206-215.

16. Cryu S.W., Bok G.H., Jang J.Y, et al. Clinically useful diagnostic tool of contrast enhanced ultrasonography for focal liver masses: comparison to computed tomography and magnetic resonance imaging. Gut Liver. 2014 May;8(3):292-7.

17. Roth C.G., Mitchell D.G. Hepatocellular Carcinoma and Other Hepatic Malignancies: MR Imaging. Radiol. Clin. North. Am. 2014 Jul;52(4):683-707.

18. Snowberger N., Chinnakotla S., Lepe R.M., et al. Alpha fetoprotein, ultrasound, computerized tomography and magnetic resonance imaging for detection of hepatocellular carcinoma in patients with advanced cirrhosis. Aliment Pharmacol. Ther. 2007;26:1187-1194.

19. Jeong W.K., Kim YK., Song K.D., et al. The MR imaging diagnosis of liver diseases using gadoxetic acid: emphasis on hepatobiliary phase. Clin. Mol. Hepatol. 2013 Dec;19(4):360-6.

20. Tumanova U.N., Karmazanovskij G.G., Schegolev A.I. Sravnitel'naja kompjuterno-tomograficheskaja harakteristika densitometricheskih pokazatelej gepatocelljuljarnogo raka i ochagovoj uzlovoj giperplazii pecheni [Comparative computed tomography characteristics of densitometric indications of hepatocellular carcinoma and focal nodular hyperplasia of liver] .Diagnosticheskaja i intervencionnaja radiologija. 2013; 7(3): 25-35 [In Russ].

21. Bialecki E.S., Di Bisceglie A.M. Diagnosis of hepatocellular carcinoma. HPB (Oxford) 2005;7:26-34.